Bicellar systems for in vitro percutaneous absorption of diclofenac

International Journal of Pharmaceutics

Volumn 386, Issue 1-2, 2010, Pages 108-113

  Rubio, L ^a   Alonso, C ^a   Rodriguez G ^a   Barbosa Barros, L ^a   Coderch, L ^a   De la Maza, A ^a   Parra, J L ^a   Lopez O ^a  

^a INSTITUTE OF ADVANCED CHEMISTRY OF CATALONIA IQAC CSIC   (Spain)

Author keywords

Bicellar systems; Diclofenac; Drug delivery system; In vitro percutaneous absorption; Vehicle

Indexed keywords

DICLOFENAC DIETHYLAMINE; DIHEXANOYLPHOSPHATIDYLCHOLINE; DIMYRISTOYLPHOSPHATIDYLCHOLINE; DIPALMITOYLPHOSPHATIDYLCHOLINE; GLYCEROPHOSPHOLIPID; UNCLASSIFIED DRUG;

ANIMAL TISSUE; AQUEOUS SOLUTION; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG DETERMINATION; DRUG PENETRATION; ENCAPSULATION; IN VITRO STUDY; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SKIN ABSORPTION; SKIN PERMEABILITY; SWINE;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHEMISTRY, PHARMACEUTICAL; DICLOFENAC; DIETHYLAMINES; DRUG CARRIERS; DRUG COMPOUNDING; KINETICS; PARTICLE SIZE; SKIN; SKIN ABSORPTION; SOLUBILITY; SWINE; TECHNOLOGY, PHARMACEUTICAL; VEHICLES;

EID: 74149094590     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2009.11.004     Document Type: Article

References (45)

1. Ainbinder D., and Touitou E. Testosterone ethosomes for enhanced transdermal delivery. Drug Deliv. 12 (2005) 297-303
2. Barbosa-Barros L., de la Maza A., Estelrich J., Linares A.M., Feliz M., Walther P., Pons R., and Lopez O. Penetration and growth of DPPC/DHPC bicelles inside the stratum corneum of the skin. Langmuir 24 (2008) 5700-5706
3. Barbosa-Barros L., De la Maza A., Walther P., Estelrich J., and Lopez O. Morphological effects of ceramide on DMPC/DHPC bicelles. J. Microsc. 230 (2008) 16-26
4. Barbosa-Barros L., Barba C., Cocera M., Coderch L., Lopez-Iglesias C., de la Maza A., and Lopez O. Effect of bicellar systems on skin properties. Int. J. Pharm. 352 (2008) 263-272
5. Barry B.W. Novel mechanisms and devices to enable successful transdermal drug delivery. Eur. J. Pharm. Sci. 14 (2001) 101-114
6. Boinpally R.R., Zhou S.L., Poondru S., Devraj G., and Jasti B.R. Lecithin vesicles for topical delivery of diclofenac. Eur. J. Pharm. Biopharm. 56 (2003) 389-392
7. Cornell B.A., Fletcher G.C., Middlehurst J., and Separovic F. The lower limit to the size of small sonicated phospholipid vesicles. Biochim. Biophys. Acta 690 (1982) 15-19
8. El Maghraby G.M., Williams A.C., and Barry B.W. Skin delivery of 5-fluorouracil from ultradeformable and standard liposomes in-vitro. J. Pharm. Pharmacol. 53 (2001) 1069-1077
9. El Maghraby G.M., Williams A.C., and Barry B.W. Skin delivery of oestradiol from deformable and traditional liposomes: mechanistic studies. J. Pharm. Pharmacol. 51 (1999) 1123-1134
10. Elias P.M., and Feingold K.R. Skin Barrier (2006), Taylor and Francis group, New York
11. Fang J.Y., Fang C.L., Liu C.H., and Su Y.H. Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC). Eur. J. Pharm. Biopharm. 70 (2008) 633-640
12. Ferreira H., Lucio M., Lima J.L.F.C., Matos C., and Reis S. Effects of diclofenac on EPC liposome membrane properties. Anal. Bioanal. Chem. 382 (2005) 1256-1264
13. Frölich M., Giannotti A., and Modell J.H. Opioid overdose in a patient using a fentanyl patch during treatment with a warming blanket. Anesth. Analg. 93 (2001) 647-648
14. Galer B.S., Rowbotham M., Perander J., Devers A., and Friedman E. Topical diclofenac patch relieves minor sports injury pain: results of a multicenter controlled clinical trial. J. Pain Symptom Manage. 19 (2000) 287-294
15. Golden G.M., Guzek D.B., Kennedy A.H., McKie J.E., and Potts R.O. Stratum corneum lipid phase transitions and water barrier properties. Biochemistry 26 (1987) 2382-2388
16. Gwak H.S., and Chun I.K. Effect of vehicles and penetration enhancers on the in vitro percutaneous absorption of tenoxicam through hairless mouse skin. Int. J. Pharm. 236 (2002) 57-64
17. Honeywell-Nguyen P.L., Frederik P.M., Bomans P.H., Junginger H.E., and Bouwstra J.A. Transdermal delivery of pergolide from surfactant-based elastic and rigid vesicles: characterization and in vitro transport studies. Pharm. Res. 19 (2002) 991-997
18. Honeywell-Nguyen P.L., and Bouwstra J.A. Vesicles as a tool for transdermal and dermal delivery. Drug Discov. Today: Technol. 2 (2005) 67-74
19. Kriwet K., and Müller-Goymann C.C. Mutual interactions between diclofenac diethylamine and phospholipids-investigation on the microstructure of the arisen systems. Pharmazie 49 (1994) 187-191
20. Kriwet K., and Müller-Goymann C.C. Diclofenac release from phospholipid drug systems and permeation through excised human stratum corneum. Int. J. Pharm. 125 (1996) 231-242
21. Kweon J.H., Chi S.C., and Park E.S. Transdermal delivery of diclofenac using microemulsions. Arch. Pharm. Res. 27 (2004) 351-356
22. Lewis R.N., Mak N., and McElhaney R.N. A differential scanning calorimetric study of the thermotropic phase behavior of model membranes composed of phosphatidylcholines containing linear saturated fatty acyl chains. Biochemistry 26 (1987) 6118-6126
23. Lopes L.B., Scarpa M.V., Silva G.V., Rodrigues D.C., Santilli C.V., and Oliveira A.G. Studies on the encapsulation of diclofenac in small unilamellar liposomes of soya phosphatidylcholine. Colloids Surf. B: Biointerfaces 39 (2004) 151-158
24. Lopes L.B., Scarpa M.V., Pereira N.L., Oliveira L.C., and Oliveira A.G. Interaction of sodium diclofenac with freeze-dried soya phosphatidylcholine and unilamellar liposomes. Rev. Bras. Cienc. Farm. 42 (2006) 497-504
25. Mezei M., and Gulasekharam V. Liposomes-a selective drug delivery system for the topical route of administration. Lotion dosage form. Life Sci. 26 (1980) 1473-1477
26. OECD, 2004. Guideline 428: skin absorption: in vitro method. In: Development, O.f.E.C.a. (Ed.), OECD Guidelines for the Testing of Chemicals. Paris, p. 8.
27. Paolino D., Lucania G., Mardente D., Alhaique F., and Fresta M. Ethosomes for skin delivery of ammonium glycyrrhizinate: in vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteers. J. Control. Release 106 (2005) 99-110
28. Parsaee S., Sarbolouki M.N., and Parnianpour M. In-vitro release of diclofenac diethylammonium from lipid-based formulations. Int. J. Pharm. 241 (2002) 185-190
29. Probstein R.F. Physicochemical Hydrodynamics (1994), John Wiley & Sons, New York
30. Puglia C., Blasi P., Rizza L., Schoubben A., Bonina F., Rossi C., and Ricci M. Lipid nanoparticles for prolonged topical delivery: an in vitro and in vivo investigation. Int. J. Pharm. 357 (2008) 295-304
31. Qiu Y., Gao Y., Hu K., and Li F. Enhancement of skin permeation of docetaxel: a novel approach combining microneedle and elastic liposomes. J. Control. Release 129 (2008) 144-150
32. Rades T., and Müller-Goymann C.C. Investigations on the micellisation behaviour of fenoprofen sodium. Int. J. Pharm. 159 (1997) 215-222
33. Schaefer H., and Redermeier T.E. Skin Barrier-Principles of Percutaneous Absorption (1996), Karger-Verlag, Basel
34. Schreier S., Malheiros S.V., and de Paula E. Surface active drugs: self-association and interaction with membranes and surfactants. Physicochemical and biological aspects. Biochim. Biophys. Acta 1508 (2000) 210-234
35. Schutze W., and Muller-Goymann C.C. Phase transformation of a liposomal dispersion into a micellar solution induced by drug-loading. Pharm. Res. 15 (1998) 538-543
36. Seddon A.M., Casey D., Law R.V., Gee A., Templer R.H., and Ces O. Drug interactions with lipid membranes. Chem. Soc. Rev. 38 (2009) 2509-2519
37. Spernath A., Aserin A., Sintov A.C., and Garti N. Phosphatidylcholine embedded micellar systems: enhanced permeability through rat skin. J. Colloid Interface Sci. 318 (2008) 421-429
38. Thong H.Y., Zhai H., and Maibach H.I. Percutaneous penetration enhancers: an overview. Skin Pharmacol. Physiol. 20 (2007) 272-282
39. Touitou E., Dayan N., Bergelson L., Godin B., and Eliaz M. Ethosomes-novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J. Control. Release 65 (2000) 403-418
40. Trotta M., Peira E., Carlotti M.E., and Gallarate M. Deformable liposomes for dermal administration of methotrexate. Int. J. Pharm. 270 (2004) 119-125
41. Trotta M., Peira E., Debernardi F., and Gallarate M. Elastic liposomes for skin delivery of dipotassium glycyrrhizinate. Int. J. Pharm. 241 (2002) 319-327
42. Visscher I., Stuart M.C., and Engberts J.B. The influence of phenyl and phenoxy modification in the hydrophobic tails of di-n-alkyl phosphate amphiphiles on aggregate morphology. Org. Biomol. Chem. 4 (2006) 707-712
43. Vold R.R., and Prosser R.S. Magnetically oriented phospholipid bilayered micelles for structural studies of polypeptides. Does the ideal bicelle exist?. J. Magn. Res. Ser. B 113 (1996) 267-271
44. Whiles J.A., Deems R., Vold R.R., and Dennis E.A. Bicelles in structure-function studies of membrane-associated proteins. Bioorg. Chem. 30 (2002) 431-442
45. Williams A.C. Transdermal and Topical Drug Delivery: From Theory to Clinical Practice (2003), Pharmaceutical Press, London